ENFLONSIA 150 mg/mL (Clesrovimab INJECTION, SOLUTION) 150 mg/mL

Enflonsia 150 mg/mL is a clesrovimab injection used for therapeutic purposes. This solution is administered intramuscularly and is supplied in a glass syringe. Learn more about its uses and effects.

Strength

150 mg/mL

Pack Size

1 SYRINGE, GLASS in 1 CARTON (0006-5073-01) / .7 mL in 1 SYRINGE, GLASS (0006-5073-99)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Enflonsia 150 mg/mL is primarily used for therapeutic interventions requiring clesrovimab. This medication is administered via intramuscular injection and is often considered for conditions that may benefit from its properties. What is Enflonsia used for? It is typically prescribed for specific therapeutic needs as determined by a healthcare provider.

Side Effects

Common effects of Enflonsia 150 mg/mL may include localized reactions at the injection site. Some individuals might experience mild discomfort or swelling. These effects are generally temporary and should be monitored. Always consult a healthcare professional for personalized advice.

Precautions & Warnings

Enflonsia 150 mg/mL should be handled with care. Ensure proper storage and administration as directed. Avoid self-administration without professional guidance. Always follow the instructions provided by your healthcare provider to minimize risks.

Avoid Interactions

Enflonsia 150 mg/mL may interact with certain medications or substances. It is important to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol and other CYP inhibitors might affect its efficacy or safety.

Frequently Asked Questions

Enflonsia 150 mg/mL is used for therapeutic purposes as determined by a healthcare provider. It is typically administered intramuscularly for specific conditions.

Enflonsia 150 mg/mL is administered via intramuscular injection. It is supplied in a glass syringe for easy administration.

Common effects may include localized reactions at the injection site, such as mild discomfort or swelling. These effects are generally temporary.

Enflonsia 150 mg/mL should be handled with care. Ensure proper storage and administration as directed. Avoid self-administration without professional guidance.

Enflonsia 150 mg/mL may interact with certain medications or substances. Inform your healthcare provider about all current medications to avoid potential interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.